The global antipyretic drugs for children market isanticipated to grow at a considerable CAGR of 5.5% during the forecast period. Technological advancements in the antipyretics drugs for children market encompass several aspects, including formulation improvements, dosage forms, and delivery methods. These advancements aim to enhance the efficacy, safety, and convenience of antipyretic medications, ultimately improving the overall treatment experience for children. For instance, in October 2020, IBSA Pharma launched a diclofenac topical system, which goes by the name of Licart, containing 1.3% diclofenac epolapime. It would be primarily distributed in the US market to treat patients suffering from acute pain caused by strains, sprains, and contusions. Moreover, it uses a patented next-generation patch technology that allows for fast onset and sustained pain relief. It was proven to provide significant pain relief within 1-3 hours after application and continues to relieve pain for 24hours.
Browse the full report description of “Antipyretic Drugs for Children Market Size, Share & Trends Analysis Report by Type (Paracetamol, Aspirin, Ibuprofen, Naproxen, and Diclofenac), by Application (Fever Reduction, Pain Relief, Common Cold and Flu Symptoms, And Others), and by Formulation (Liquid Suspensions, Chewable Tablets, Dissolvable Tablets, Suppositories, and Oral Powders)T)Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/antipyretic-drugs-for-children-market
Major companies operating in the market are introducing innovative and new products to sustain their position in the market. For instance, in August 2021, PLx Pharma, a US-based specialty pharmaceutical company, launched VAZALORE 325 mg and VAZALORE 81 mg liquid-filled aspirin capsules. It is the first US FDA-approved liquid-filled aspirin capsule which is beneficial in avoiding stomach erosions and ulcers. In March 2022 Paraveganio became one of the first medicinal products in the world to be registered with The Vegan Society’s Vegan Trademark. The certified vegan drug contains 500mg of the proven active ingredient paracetamol.In February 2020, Lincoln Pharmaceutical received a nod from the DGCI, India for their liquid diclofenac metered-dose rectal spray. The spray offers better absorption, which makes the person feel relieved in a quick time.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o Type
o Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including GSK plc, Johnson & Johnson Services, Inc, Pfizer Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Antipyretic Drugs for Children MarketReport Segment
By Type
By Application
By Formulation
Global Antipyretic Drugs for Children Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/antipyretic-drugs-for-children-market